ARAlireza Rahmani

Alireza Rahmani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alireza Rahmani has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Study of Acute Myocardial Infarctions Triggers in North-Western Iran

    by Kamal Khademvatani, Amin Sedokani, Sima Masudi, Parisa Nejati, Mir Hosein Seyyed Mohammadzad, Alireza Rahmani

    Background: Myocardial infarction (MI) is one of the important cardiovascular diseases. A trigger is an external stimulus, potential to create a pathological change leading to a clinical event. In addition to the risk factors of myocardial infarction, MI triggers play critical roles in the incidence of acute MI. Methods and Results: This is a cross-sectional study of patients with the first acute myocardial infarction in Seyedoshohada heart center of Urmia, Iran. 254 patients were enrolled in the study within one year of study. After 48 h of hospitalization, the patients were provided with the questionnaire to collecting the history of the disease ad triggers. Out of 220 (86.4%) patients with STEMI and 34 (13.6%) patients with NSTEMI, there were significant differences (p 2 . Conclusion: In addition to classic risk factors of myocardial infarction, health care systems must pay more attention to triggers that may induce an acute myocardial infarction in people with predisposing factors especially in the male sex, stressful and hand working jobs, and psychological and mental tension patients.

  • Open Access

    Health Impacts of Long-term Exposure to Disinfectants During SARS-Cov-2 Pandemic

    by Ali Reza Rahamani, Ghasem Azarian, Ali Poormohammadi

    Health Impacts of Long-term Exposure to Disinfectants During SARS-Cov-2 Pandemic


  • Open Access

    Effect of oral vitamin C on atrial fibrillation development after isolated coronary artery bypass grafting surgery: A prospective randomized clinical trial

    by Mohammad Reza Dehghani, Nader Madjidi, Alireza Rahmani, Behnam Asgari, Yousef Rezaei

    Some evidences have shown the role of antioxidant vitamins in preventing atrial fibrillation (AF) after coronary artery bypass grafting (CABG) surgery. We sought to determine the effect of oral vitamin C on the incidence of postoperative AF in patients undergoing elective isolated on-pump CABG surgery. One-hundred patients who underwent isolated CABG surgery were prospectively assigned into two groups: Group 1 - 50 patients received 2 g of oral vitamin C before and 500 mg twice daily lasting for 5 days after surgery; Group 2 - 50 patients as the control group did not receive any. All patients were continuously monitored after surgery in the intensive careunit (ICU), and then Holter monitoring was implemented for 72 h. The mean of patients' age was 61.31 ± 6.42 years. Postoperative AF occurred in 16 and 4 patients in control and treatment groups, respectively (32% vs. 8%, p = 0.003). The ICU stay was 1.79 ± 0.313 and 2.10 ± 0.61 days for vitamin C and control groups, respectively (p = 0.002). The hospital stay was significantly lower in vitamin C group compared with that of the control group (5.32 ± 0.59 vs. 5.74 ± 1.30 days, respectively, p = 0.041). Baseline erythrocyte sedimentation rate (OR 1.030, 95% CI 1.003-1.058, p = 0.030) and taking vitamin C (OR 8.068, 95% CI 1.783-36.517, p = 0.007) were the independent predictors of postoperative AF. Oral vitamin C can be safely used to decrease the incidence of postoperative AF in patients undergoing elective isolated on-pump CABG surgery.